AAV Anion-Exchange Elution for Full-Empty Particle Separation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing methods for separating full and empty recombinant adeno-associated virus (rAAV) particles are inefficient, leading to inconsistencies in gene therapy efficacy due to the presence of empty particles, which affect the quality and efficiency of therapeutic delivery.

Innovation Solution

An anion-exchange chromatography method with a novel elution scheme that utilizes a sequence of buffered solutions with controlled pH and conductivity changes to achieve precise baseline separation and quantification of full and empty rAAV particles.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If conventional linear gradient elution is used in anion exchange chromatography, then the method is simple to operate, but the resolution between full and empty rAAV particles is insufficient

Engineering Contradiction:
ImproveresolutionVSAvoidelution scheme complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The elution process is divided into multiple discrete steps with different buffered solutions having specific pH and conductivity values. The method segments the gradient into distinct phases (loading, washing, elution, regeneration) with controlled transitions, allowing precise separation of full and empty particles while maintaining operational structure

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The method systematically changes buffer parameters (pH and conductivity) at controlled rates during different elution steps. By adjusting these parameters in a staged manner rather than continuously, the method achieves enhanced resolution (3.7 times higher than linear gradient) while keeping the protocol manageable through defined parameter ranges and transition rates

Inventive Principle:
Principle #35Parameter changes

2Manufacturing precision

If conventional methods are used to separate full and empty rAAV particles, then the process is simpler, but the separation efficiency and quantification accuracy are lower

Engineering Contradiction:
Improveseparation accuracyVSAvoidthroughput
Core Design Contradiction:
Manufacturing precisionVSProductivity

Solution Approach 1:

The method performs preliminary washing steps with buffered solutions of specific conductivity values before elution to ensure complete removal of non-specifically bound particles. This preliminary action prevents co-elution and establishes a clean baseline, improving separation accuracy without significantly extending total run time when integrated into the full protocol

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The elution process maintains continuous flow of buffered solutions through the column throughout all steps (loading, washing, elution, regeneration). This continuous operation allows multiple samples to be processed through the same system sequentially, maintaining high productivity while achieving accurate separation and quantification through the defined multi-step protocol

Inventive Principle:
Principle #20Continuity of useful action

3Measurement precision

If a multi-step elution protocol with controlled pH and conductivity changes is implemented, then baseline separation and quantification of full and empty particles is achieved, but the method complexity increases

Engineering Contradiction:
Improvequantification accuracyVSAvoidoperational simplicity
Core Design Contradiction:
Measurement precisionVSEase of operation

Solution Approach 1:

The method defines specific pH and conductivity values for each buffered solution used in different steps, with controlled transition rates between steps. This systematic parameter control achieves accurate quantification by ensuring complete elution of empty particles in early steps and full particles in later steps, while the predefined parameter ranges make the protocol reproducible and operable

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The method includes monitoring steps to detect when elution is complete for each particle type, allowing adjustment of subsequent step durations based on actual elution progress. This feedback mechanism ensures accurate quantification while preventing unnecessary extension of the protocol, balancing precision with operational efficiency

Inventive Principle:
Principle #23Feedback

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The method provides a resolution gain of 3.7 times higher than linear gradients, enabling accurate and efficient separation and quantification of full and empty rAAV particles, suitable for quality control and high-throughput applications.

Implementation Method 1

anion exchange chromatography (AEX) method

Methodology Applied
Scientific EffectAnion exchange: Ion Exchange

Implementation Method 2

chromatography column comprising an anion exchange (AEX) chromatography material

Methodology Applied
Scientific EffectIonic interaction: Ion Repulsion/Attraction

Data Source

PatentUS20260028598A1Method for separating full and empty AAV particles
Publication Date: 2026.01.29 F HOFFMANN LA ROCHE INC
  • US20260028598A1 patent drawing
  • US20260028598A1 patent drawing
  • US20260028598A1 patent drawing

AI summary

Herein is reported a method for separating full and empty recombinant adeno-associated virus particles using an anion exchange chromatography step, wherein the method comprises a sequence of a applying a solution comprising empty and/or full rAAV particles to an anion exchange chromatography material inside a chromatography column, a first isocratic step, a first linear gradient, a second isocratic step and a second linear gradient, wherein the empty recombinant adeno-associated virus particles are eluted during the first linear gradient and the full recombinant adeno-associated virus particles are eluted during the second linear gradient. In certain embodiments, the solution applied in the first isocratic step comprises about 65 mM of the buffer substance, about 10 mM of the elution salt, about 2 mM of the salt and has a pH value of about 9.4. In certain embodiments, the solution applied in the second isocratic step comprises about 65 mM of the buffer substance, about 90 mM of the elution salt, about 2 mM of the salt and has a pH value of about 9.4. In certain embodiments, the buffer substance is N-(1,1-Dimethyl-2-hydroxyethyl)-3-amino-2-hydroxypropane sulfonic acid, the elution salt is tetramethyl ammonium chloride, and the salt is magnesium chloride.